4.4 Article

Posttraumatic Stress Disorder and Risk of Systemic Lupus Erythematosus Among Medicaid Recipients

Journal

ARTHRITIS CARE & RESEARCH
Volume 75, Issue 1, Pages 174-179

Publisher

WILEY
DOI: 10.1002/acr.24758

Keywords

-

Categories

Ask authors/readers for more resources

This study explored the association between posttraumatic stress disorder (PTSD) and systemic lupus erythematosus (SLE). It found that patients with a prior PTSD diagnosis had twice the odds of developing SLE.
Objective We studied posttraumatic stress disorder (PTSD), a severe trauma-related mental disorder, and systemic lupus erythematosus (SLE) risk in a large, diverse population enrolled in Medicaid, a US government-sponsored health insurance program for low-income individuals. Methods We identified SLE cases and controls among patients ages 18-65 years enrolled in Medicaid for >= 12 months in the 29 most populated US states from 2007 to 2010. SLE and PTSD case statuses were defined based on validated patterns of International Classification of Diseases, Ninth Revision codes. Index date was the date of the first SLE code. Controls had no SLE codes but had another inpatient or outpatient code on the index date and were matched 1:10 to cases by age, sex, and race. Conditional logistic regressions calculated odds ratios (ORs) and 95% confidence intervals (95% CIs) for the association of PTSD with incident SLE, adjusting for smoking, obesity, oral contraceptive use, and other covariates. Results A total of 10,942 incident SLE cases were matched to 109,420 controls. The prevalence of PTSD was higher in SLE cases, at 10.74 cases of PTSD per 1,000 person-years (95% CI 9.37-12.31) versus 7.83 cases (95% CI 7.42-8.27) in controls. The multivariable-adjusted OR for SLE among those with PTSD was 2.00 (95% CI 1.64-2.46). Conclusion In this large, racially and sociodemographically diverse US population, we found patients with a prior PTSD diagnosis had twice the odds of a subsequent diagnosis of SLE. Studies are necessary to clarify the mechanisms driving the observed association and to inform possible interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Comparison of an administrative algorithm for SLE disease severity to clinical SLE Disease Activity Index scores

Cameron B. Speyer, Daniel Li, Hongshu Guan, Kazuki Yoshida, Emma Stevens, April M. Jorge, Brendan M. Everett, Candace H. Feldman, Karen H. Costenbader

RHEUMATOLOGY INTERNATIONAL (2020)

Article Rheumatology

Treat-to-Target Approach in Rheumatoid Arthritis: A Quality Improvement Trial

Sonali P. Desai, Cianna Leatherwood, Malka Forman, Eunji Ko, Emma Stevens, Maura Iversen, Chang Xu, Bing Lu, Daniel H. Solomon

Summary: Using a quality improvement approach, this study integrated a treat-to-target approach for rheumatoid arthritis (RA) through routine electronic collection of patient-reported disease activity scores and a multidisciplinary learning collaborative for rheumatologists. The results showed a significant increase in treat-to-target implementation scores among intervention rheumatologists compared to the control group, with a lower likelihood of medication changes in the intervention group for patients with high RAPID3 scores.

ARTHRITIS CARE & RESEARCH (2021)

Article Rheumatology

Interactions Between Genome-Wide Genetic Factors and Smoking Influencing Risk of Systemic Lupus Erythematosus

Jing Cui, Soumya Raychaudhuri, Elizabeth W. Karlson, Cameron Speyer, Susan Malspeis, Hongshu Guan, Jeffrey A. Sparks, Hongru Ni, Xinyi Liu, Emma Stevens, Jessica N. Williams, Emma E. Davenport, Rachel Knevel, Karen H. Costenbader

ARTHRITIS & RHEUMATOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders

Brittany N. Weber, Emma Stevens, Lourdes M. Perez-Chada, Jenifer M. Brown, Sanjay Divakaran, Camden Bay, Courtney Bibbo, Jon Hainer, Sharmila Dorbala, Ron Blankstein, Viviany R. Taqueti, Joseph F. Merola, Elena Massarotti, Karen Costenbader, Katherine Liao, Marcelo F. Di Carli

JACC-CARDIOVASCULAR IMAGING (2020)

Article Rheumatology

Patient experiences and strategies for coping with SLE: A qualitative study

Siobhan Case, Corine Sinnette, Courtnie Phillip, Claire Grosgogeat, Karen H. Costenbader, Cianna Leatherwood, Candace H. Feldman, Mary Beth Son

Summary: This study explored challenges faced by SLE and cSLE patients, identifying modifiable influences and coping strategies based on personal experiences. Participants identified five primary challenges with SLE, including diagnostic odyssey, public versus private face of SLE, SLE-related stresses, medication adherence, and transitioning from pediatric to adult care. Coping strategies and modifiable factors such as social support, open communication about SLE, and strong patient-provider relationships were highlighted.

LUPUS (2021)

Article Rheumatology

Association of a Combination of Healthy Lifestyle Behaviors With Reduced Risk of Incident Systemic Lupus Erythematosus

May Y. Choi, Jill Hahn, Susan Malspeis, Emma F. Stevens, Elizabeth W. Karlson, Jeffrey A. Sparks, Kazuki Yoshida, Laura Kubzansky, Karen H. Costenbader

Summary: This study found that adherence to a combination of healthy lifestyle factors is associated with a lower risk of incident systemic lupus erythematosus (SLE). Women with more healthy lifestyle factors had the lowest risk of SLE. Assuming adherence to at least 4 healthy lifestyle behaviors in the entire population, the risk of developing SLE could be reduced by approximately 50%.

ARTHRITIS & RHEUMATOLOGY (2022)

Letter Rheumatology

Untitled Reply

May Y. Choi, Jill Hahn, Susan Malspeis, Emma F. Stevens, Elizabeth W. Karlson, Jeffrey A. Sparks, Kazuki Yoshida, Laura Kubzansky, Karen H. Costenbader

ARTHRITIS & RHEUMATOLOGY (2022)

Article Pediatrics

Implications of Evolving Disease Classification for Drug Approval in Juvenile Idiopathic Arthritis

Siobhan M. Case, Peter A. Nigrovic

Summary: The classification of inflammatory arthritis separates childhood onset diseases from those that start in adulthood. However, it is now clear that most forms of arthritis transcend the pediatric/adult boundary and that drugs generally show comparable success, regardless of age of onset, which offers new opportunities in drug development and regulation focused on pharmacology and safety.

PEDIATRIC DRUGS (2022)

Article Rheumatology

Recognizing Racial Bias and Promoting Diversity in the Rheumatology Workforce

Siobhan M. Case, Gail S. Kerr, Mia Chandler, Valerie E. Stone, Irene Blanco, Candace H. Feldman

ARTHRITIS & RHEUMATOLOGY (2022)

Article Rheumatology

Safety of the Zoster Vaccine Recombinant Adjuvanted in Rheumatoid Arthritis and Other Systemic Rheumatic Disease Patients: A Single Center's Experience With 400 Patients

Emma Stevens, Michael E. Weinblatt, Elena Massarotti, Frances Griffin, Srinivas Emani, Sonali Desai

ACR OPEN RHEUMATOLOGY (2020)

Article Health Care Sciences & Services

Improving Quality of Care in Rheumatoid Arthritis Through Mobile Patient-Reported Outcome Measurement: Focus Group Study

Sonali Desai, Emma Stevens, Srinivas Emani, Peter Meyers, Maura Iversen, Daniel H. Solomon

JMIR FORMATIVE RESEARCH (2020)

No Data Available